...
首页> 外文期刊>Archives of gynecology and obstetrics. >Comprehensive genetic assessment of the human embryo: can empiric application of microarray comparative genomic hybridization reduce multiple gestation rate by single fresh blastocyst transfer?
【24h】

Comprehensive genetic assessment of the human embryo: can empiric application of microarray comparative genomic hybridization reduce multiple gestation rate by single fresh blastocyst transfer?

机译:人类胚胎的全面遗传评估:微阵列比较基因组杂交的经验性应用是否可以通过单次新鲜囊胚转移降低多胎妊娠率?

获取原文
获取原文并翻译 | 示例

摘要

The unacceptable multiple gestation rate currently associated with in vitro fertilization (IVF) would be substantially alleviated if the routine practice of transferring more than one embryo were reconsidered. While transferring a single embryo is an effective method to reduce the clinical problem of multiple gestation, rigid adherence to this approach has been criticized for negatively impacting clinical pregnancy success in IVF. In general, single embryo transfer is viewed cautiously by IVF patients although greater acceptance would result from a more effective embryo selection method.Selection of one embryo for fresh transfer on the basis of chromosomal normalcy should achieve the dual objective of maintaining satisfactory clinical pregnancy rates and minimizing the multiple gestation problem, because embryo aneuploidy is a major contributing factor in implantation failure and miscarriage in IVF. The initial techniques for preimplantation genetic screening unfortunately lacked sufficient sensitivity and did not yield the expected results in IVF. However, newer molecular genetic methods could be incorporated with standard IVF to bring the goal of single embryo transfer within reach.Aiming to make multiple embryo transfers obsolete and unnecessary, and recognizing that array comparative genomic hybridization (aCGH) will typically require an additional 12?h of laboratory time to complete, we propose adopting aCGH for mainstream use in clinical IVF practice.As aCGH technology continues to develop and becomes increasingly available at lower cost, it may soon be considered unusual for IVF laboratories to select a single embryo for fresh transfer without regard to its chromosomal competency. In this report, we provide a rationale supporting aCGH as the preferred methodology to provide a comprehensive genetic assessment of the single embryo before fresh transfer in IVF. The logistics and cost of integrating aCGH with IVF to enable fresh embryo transfer are also discussed.
机译:如果重新考虑转移一个以上胚胎的常规做法,将大大减轻目前与体外受精(IVF)相关的不可接受的多次妊娠率。虽然转移单个胚胎是减少多胎妊娠临床问题的有效方法,但严格遵守该方法已受到批评,因为它会对IVF的临床妊娠成功产生负面影响。一般而言,IVF患者会谨慎地考虑单个胚胎的移植,尽管更有效的胚胎选择方法会获得更大的接受度。基于染色体正常性选择一个胚胎进行新鲜移植应该达到维持令人满意的临床妊娠率和维持妊娠的双重目标。最大限度地减少多胎妊娠问题,因为胚胎非整倍性是导致IVF着床失败和流产的主要因素。不幸的是,用于植入前遗传筛选的初始技术缺乏足够的敏感性,并且在IVF中未产生预期的结果。但是,可以将新的分子遗传学方法与标准的IVF结合使用,以实现单胚胎移植的目标。旨在使多次胚胎移植变得过时和不必要,并且认识到阵列比较基因组杂交(aCGH)通常需要额外的12个?在完成实验室时间后,我们建议采用aCGH作为IVF临床实践的主流应用。随着aCGH技术的不断发展和低成本的日益普及,IVF实验室选择单个胚胎进行新鲜移植可能很快被认为是不寻常的不考虑其染色体能力。在本报告中,我们提供了支持aCGH作为首选方法的原理,以在IVF中新鲜转移之前对单个胚胎进行全面的遗传评估。还讨论了将aCGH与IVF整合以实现新鲜胚胎移植的物流和成本。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号